Arizona State Retirement System’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-27,093
Closed -$105K 2163
2024
Q3
$105K Buy
27,093
+858
+3% +$3.62K ﹤0.01% 2101
2024
Q2
$103K Buy
26,235
+1,950
+8% +$8.39K ﹤0.01% 2041
2024
Q1
$102K Sell
24,285
-320
-1% -$1.5K ﹤0.01% 2077
2023
Q4
$116K Sell
24,605
-355
-1% -$1.38K ﹤0.01% 2081
2023
Q3
$77.9K Buy
24,960
+392
+2% +$1.58K ﹤0.01% 2108
2023
Q2
$113K Buy
24,568
+3,870
+19% +$17.8K ﹤0.01% 2101
2023
Q1
$102K Buy
20,698
+605
+3% +$2.98K ﹤0.01% 2108
2022
Q4
$110K Buy
20,093
+778
+4% +$4.77K ﹤0.01% 2092
2022
Q3
$126K Buy
19,315
+59
+0.3% +$329 ﹤0.01% 2044
2022
Q2
$91K Buy
19,256
+1,538
+9% +$7.58K ﹤0.01% 2134
2022
Q1
$124K Buy
17,718
+152
+0.9% +$1.04K ﹤0.01% 2121
2021
Q4
$179K Buy
+17,566
New +$189K ﹤0.01% 2114

Other funds holding MXCT

Arizona State Retirement System's MXCT Position: Q4 2024 in Review

Arizona State Retirement System sold out of MaxCyte (MXCT) in Q4 2024, closing a stake of 27,093 shares — an estimated $105K sold.

Arizona State Retirement System first reported a position in MXCT in Q4 2021 and held it in 12 quarters. The position peaked at $179K in Q4 2021. 119 funds tracked by Wall St. Rank hold MXCT as of Q4 2024.

  • Arizona State Retirement System reported no remaining MaxCyte position as of Q4 2024 after selling out during the quarter.
  • Arizona State Retirement System sold 27,093 MaxCyte shares in Q4 2024, an estimated $105K.
  • Arizona State Retirement System first reported a position in MaxCyte in Q4 2021 and held it in 12 quarters.
  • Arizona State Retirement System's MaxCyte position peaked at $179K in Q4 2021.
  • 119 funds tracked by Wall St. Rank held MaxCyte as of Q4 2024.

Based on Arizona State Retirement System's 13F filing for Q4 2024, filed 6 Feb 2025.